ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

Conflicting results concerning the ability of the epidermal growth factor (EGF) receptor to associate with and/or activate phosphatidylinositol (PtdIns) 3-kinase have been published. Despite the ability of EGF to stimulate the production of PtdIns 3-kinase products and to cause the appearance of PtdIns 3-kinase activity in antiphosphotyrosine immunoprecipitates in several cell lines, we did not detect EGF-stimulated PtdIns 3-kinase activity in anti-EGF receptor immunoprecipitates. This result is consistent with the lack of a phosphorylated Tyr-X-X-Met motif, the p85 Src homology 2 (SH2) domain recognition sequence, in this receptor sequence. The EGF receptor homolog, ErbB2 protein, also lacks this motif. However, the ErbB3 protein has seven repeats of the Tyr-X-X-Met motif in the carboxy-terminal unique domain. Here we show that in A431 cells, which express both the EGF receptor and ErbB3, PtdIns 3-kinase coprecipitates with the ErbB3 protein (p180erbB3) in response to EGF. p180erbB3 is also shown to be tyrosine phosphorylated in response to EGF. In contrast, a different mechanism for the activation of PtdIns 3-kinase in response to EGF occurs in certain cells (PC12 and A549 cells). Thus, we show for the first time that ErbB3 can mediate EGF responses in cells expressing both ErbB3 and the EGF receptor.

[1]  L. Cantley,et al.  The erbB3 gene product is a receptor for heregulin. , 1994, The Journal of biological chemistry.

[2]  M. Kraus,et al.  Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members , 1994, Molecular and cellular biology.

[3]  D. Tuveson,et al.  CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. , 1993, Science.

[4]  M. Kraus,et al.  Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[6]  G. Plowman,et al.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Kahn,et al.  Expression and function of IRS-1 in insulin signal transmission. , 1992, The Journal of biological chemistry.

[8]  R. Bradshaw,et al.  Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Schaffhausen,et al.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase , 1992, Journal of virology.

[10]  L. Cantley,et al.  Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. , 1992, The Journal of biological chemistry.

[11]  S. Volinia,et al.  Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit , 1992, Cell.

[12]  C. Downes,et al.  Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells. , 1992, The Journal of biological chemistry.

[13]  N. Lemoine,et al.  Expression of the c-erbB-3 protein in normal human adult and fetal tissues. , 1992, Oncogene.

[14]  Y. Yarden,et al.  Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. , 1992, The Journal of biological chemistry.

[15]  L. Tertoolen,et al.  Epidermal growth factor-activated calcium and potassium channels. , 1991, The Journal of biological chemistry.

[16]  J. Putney,et al.  Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells. , 1991, Molecular pharmacology.

[17]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[18]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[19]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[20]  T. Hunter,et al.  Interaction between the epidermal growth factor receptor and phosphoinositide kinases. , 1991, The Journal of biological chemistry.

[21]  E. Chambaz,et al.  Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells. , 1990, Biochemical Journal.

[22]  M. Ascoli,et al.  Anti-phosphotyrosine immunoprecipitation of phosphatidylinositol 3' kinase activity in different cell types after exposure to epidermal growth factor. , 1990, Biochemical and biophysical research communications.

[23]  L. Cantley,et al.  Purification and characterization of phosphoinositide 3-kinase from rat liver. , 1990, The Journal of biological chemistry.

[24]  G. Plowman,et al.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Kung,et al.  Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Lapetina,et al.  Thrombin stimulates the production of a novel polyphosphoinositide in human platelets. , 1990, The Journal of biological chemistry.

[27]  L. Cantley,et al.  Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  O. Pignataro,et al.  Epidermal growth factor increases the labeling of phosphatidylinositol 3,4-bisphosphate in MA-10 Leydig tumor cells. , 1990, Journal of Biological Chemistry.

[29]  R. Roth,et al.  Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. , 1990, The Journal of biological chemistry.

[30]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Taylor,et al.  Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. , 1989, The Journal of biological chemistry.

[32]  A. Zilberstein,et al.  EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling , 1989, Cell.

[33]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[34]  G. Carpenter,et al.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Schlessinger,et al.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB‐2 protein in the mammary tumor cell line SK‐BR‐3. , 1988, The EMBO journal.

[36]  O. Rosen.  After insulin binds. , 1987, Science.

[37]  T. Lovenberg,et al.  Epidermal growth factor stimulates the rapid accumulation of inositol (1,4,5)-trisphosphate and a rise in cytosolic calcium mobilized from intracellular stores in A431 cells. , 1987, The Journal of biological chemistry.

[38]  L. Pike,et al.  Epidermal growth factor stimulates the production of phosphatidylinositol monophosphate and the breakdown of polyphosphoinositides in A431 cells. , 1987, The Journal of biological chemistry.

[39]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[40]  E. Chambaz,et al.  Separation and characterization of a phosphatidylinositol kinase activity that co-purifies with the epidermal growth factor receptor. , 1985, The Journal of biological chemistry.

[41]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.